Therapeutic enhancement of blood–brain and blood–tumor barriers permeability by laser interstitial thermal therapy

Abstract

Together, these results suggest that LITT can locally disrupt the BBB and BTB, enabling the targeted delivery of systemic therapies, including, potentially, antibody-based agents.